Correction to: Gene Therapy (2006) 13, 1057–1059. doi:10.1038/sj.gt.3302752
Since the above publication the authors have noticed an error in the first DNA marker of FRA11E in Supplementary Table 1S. The correct table is shown below:
The authors would like to apologise for this error.
Additional information
The online version of the original article can be found at 10.1038/sj.gt.3302752
Rights and permissions
About this article
Cite this article
Bester, A., Schwartz, M., Schmidt, M. et al. Erratum: Fragile sites are preferential targets for integrations of MLV vectors in gene therapy. Gene Ther 14, 282 (2007). https://doi.org/10.1038/sj.gt.3302904
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302904
